Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-03

Clinical Trial Update: Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the efficacy and safety of Ingenol Mebutate Gel for actinic keratosis when applied to large areas on the face, scalp, or chest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ingenol Mebutate Gel (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2018-10-03